Implantable sensor and method for detecting at least one analyte in a body fluid

Patent metadata

Field	Value
Publication number	US-11224365-B2
Application number	US-201916515984-A
Country	US
Kind code	B2
Filing date	Jul 18, 2019
Priority date	Jan 23, 2017
Publication date	Jan 18, 2022
Grant date	Jan 18, 2022

Abstract

Disclosed is a fully implantable sensor for detecting at least one analyte in a sample of body fluid. The sensor has a measurement chamber plate that receives the sample of bodily fluid and a quantum cascade laser illumination source that generates an illumination light beam in the spectral range and transmits it to the measurement chamber plate. The illumination light beam at least partially illuminates the measurement chamber plate and the measurement chamber plate generates a reflection light beam in response to the illumination by the illumination light beam. The reflection light beam at least partially illuminates the sample of body fluid within the measurement chamber plate. An optical detector detects at least one property of the reflection light beam and generates a sensor signal dependent on the presence of the analyte. A controlled evaluates the sensor signal. A method using an inventive fully implantable sensor is also disclosed.

First claim

What is claimed is:

1. A fully implantable sensor for detecting at least one analyte in a sample of body fluid, the sensor comprising:
a measurement chamber plate configured to receive the sample of bodily fluid;
a quantum cascade laser illumination source configured to generate an illumination light beam in a spectral range and to transmit the illumination light beam to the measurement chamber plate, wherein:
the illumination light beam is configured to at least partially illuminate the measurement chamber plate,
the measurement chamber plate is configured to generate a reflection light beam in response to the illumination by the illumination light beam, and
the reflection light beam is configured to at least partially illuminate the sample of body fluid within the measurement chamber plate;

an optical detector configured to detect at least one property of the reflection light beam and to generate a sensor signal dependent on the presence of the analyte; and
a controller configured to evaluate the sensor signal;
wherein the measurement chamber plate comprises first and second chamber walls forming a capillary adapted to receive the sample of body fluid.

2. The fully implantable sensor according to claim 1 , wherein the quantum cascade laser is selected from the group consisting of: a fixed-frequency Fabry-Pérot quantum cascade laser; a tunable external cavity quantum cascade laser; a distributed feedback quantum cascade laser.

3. The fully implantable sensor according to claim 1 , wherein the illumination light beam has a wavelength in the infrared spectral range.

4. The fully implantable sensor according to claim 1 , wherein measurement chamber plate comprises at least one membrane.

5. The fully implantable sensor according to claim 1 , wherein the first chamber wall is configured to receive the sample of body fluid.

6. The fully implantable sensor according to claim 5 , wherein the first chamber wall is at least partially transparent to the illumination light beam and has an at least partially transparent first infrared window.

7. The fully implantable sensor according to claim 6 , wherein the second chamber wall is adapted to at least partially receive the sample of body fluid.

8. The fully implantable sensor according to claim 7 , wherein the second chamber wall comprises an at least partially reflective second infrared window configured for transport of the analyte into the capillary.

9. The fully implantable sensor according to claim 8 , wherein the second chamber wall comprises a membrane.

10. The fully implantable sensor according to claim 1 , wherein the measurement chamber plate comprises at least one attenuated total reflection element having an ATR-crystal arranged to reflect the illumination light beam at least once.

11. The fully implantable sensor according to claim 1 , wherein the optical detector comprises a pyroelectric photodetector.

12. The fully implantable sensor according to claim 1 , wherein the controller is configured to generate information on the analyte by evaluating the sensor signal.

13. The fully implantable sensor according to claim 12 , wherein the controller is configured to perform a temperature correction.

14. The fully implantable sensor according to claim 1 , wherein the sensor comprises a rechargeable battery configured for contactless charging.

15. A kit for detecting at least one analyte in a sample of body fluid, the kit comprising:
the fully implantable sensor according to claim 14 ; and
an energy source configured to provide energy to the battery.

16. The fully implantable sensor of claim 1 , wherein the first and second chamber walls define a measurement cuvette.

17. A method for detecting at least one analyte in a sample of body fluid, the method comprising:
receiving the sample of body fluid in a measurement chamber plate;
generating an illumination light beam in a spectral range and transmitting the illumination light beam to the measurement chamber plate;
at least partially illuminating the measurement chamber plate with the illumination light beam;
generating at least one reflection light beam in response to the illumination by the illumination light beam;
at least partially illuminating the sample of body fluid within the measurement chamber plate with the reflection light beam;
detecting at least one property of the reflection light beam and generating at least one sensor signal dependent on the presence of the analyte by using at least one optical detector; and
evaluating the sensor signal using a controller;
wherein the receiving of the sample of body fluid in the measurement chamber plate comprises receiving the sample of body fluid in a capillary formed by first and second chamber walls.

18. The method according to claim 17 , further comprising providing the illumination light beam using a quantum cascade laser.

19. The method of claim 17 , comprising providing the measurement chamber plate, a light source that generates the illumination light beam, the optical detector and the controller inside a housing for a fully implantable sensor.

20. The method of claim 19 , comprising providing the fully implantable sensor with a rechargeable battery.

21. A fully implantable sensor for detecting at least one analyte in a sample of body fluid, the sensor comprising:
a measurement chamber plate configured to receive the sample of bodily fluid;
a quantum cascade laser illumination source configured to generate an illumination light beam in a spectral range and to transmit the illumination light beam to the measurement chamber plate, wherein:
the illumination light beam is configured to at least partially illuminate the measurement chamber plate,
the measurement chamber plate is configured to generate a reflection light beam in response to the illumination by the illumination light beam, and
the reflection light beam is configured to at least partially illuminate the sample of body fluid within the measurement chamber plate;

an optical detector configured to detect at least one property of the reflection light beam and to generate a sensor signal dependent on the presence of the analyte; and
a controller configured to evaluate the sensor signal;
wherein the measurement chamber plate comprises an ATR-crystal having a microstructure adapted to receive the sample of body fluid.

22. The fully implantable sensor of claim 21 , wherein the microstructure forms a capillary adapted to receive the sample of body fluid.

Assignees

• Roche Diabetes Care Inc

Inventors

• Deck Frank
• List Hans
• Petrich Wolfgang
• Kroeger-Lui Niels
• Haase Katharina

Classifications

• A61B5/686

  Permanently implanted devices, e.g. pacemakers, other stimulators, biochips (A61B5/6861 takes precedence) · CPC title

• A61B2560/0214

  of power generation or supply · CPC title

• A61B5/14532 Primary

  for measuring glucose, e.g. by tissue impedance measurement · CPC title

• A61B5/1459 Primary

  invasive, e.g. introduced into the body by a catheter · CPC title

• A61B5/1455

  using optical sensors, e.g. spectral photometrical oximeters · CPC title